anti phospho cjun (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
86
Structured Review
Cell Signaling Technology Inc
anti phospho cjun
Anti Phospho Cjun, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cjun/pm41579710-74-36-42
Average 86 stars, based on 1 article reviews
Anti Phospho Cjun, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cjun/pm41579710-74-36-42
Average 86 stars, based on 1 article reviews
anti phospho cjun - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
other:Article Title: A neuroprotective agent that inactivates prodegenerative TrkA and preserves mitochondria. Article Snippet: The following primary antibodies were used for IHC and WBs: anti–βIII-tubulin (rabbit, IHC, 1:1,000; PRB-435P; Covance), anti– βIII-tubulin (mouse, IHC, 1:1,000; MMS-435P; Covance), anti-caspr, (rabbit, IHC, 1:1,000, provided by E. Peles, Weizmann Institute, Rehovot, Israel), anti–pan Na+ channels (mouse, IHC, 1:1,000; S8809; Sigma-Aldrich); Modification:Article Title: Cirsium setidens Nakai extract and pectolinarin as active compounds promote innate immunity in RAW 264.7 cells and splenocytes Article Snippet: .. Dulbecco’s modified Eagle Medium (DMEM), Roswell Park Memorial Institute (RPMI)-1640 medium, penicillin-streptomycin, and fetal bovine serum (FBS) were purchased from HyClone (Logan, UT, USA). p- ERK 1/2 (#4370), ERK 1/2 (#9102), p-JNK 1/2 (#4688), JNK 1/2 (#9252), p-p38 (#4511), p38 (#9212), Synthesized:Article Title: Targeting a master inflammatory switch in the aging cochlea attenuates sensory decline Article Snippet: .. Primary antibodies used were: p-RELA (Ser536) (Cell Signaling, #3033, 1:1000), RELA (Cell Signaling, #8242, 1:1000), cDNA Synthesis:Article Title: Targeting a master inflammatory switch in the aging cochlea attenuates sensory decline Article Snippet: .. Primary antibodies used were: p-RELA (Ser536) (Cell Signaling, #3033, 1:1000), RELA (Cell Signaling, #8242, 1:1000), Real-time Polymerase Chain Reaction:Article Title: Targeting a master inflammatory switch in the aging cochlea attenuates sensory decline Article Snippet: .. Primary antibodies used were: p-RELA (Ser536) (Cell Signaling, #3033, 1:1000), RELA (Cell Signaling, #8242, 1:1000), SYBR Green Assay:Article Title: Targeting a master inflammatory switch in the aging cochlea attenuates sensory decline Article Snippet: .. Primary antibodies used were: p-RELA (Ser536) (Cell Signaling, #3033, 1:1000), RELA (Cell Signaling, #8242, 1:1000), Blocking Assay:Article Title: The inhibition of Il1β synthesis mediated by a novel pyridine-sulfonamide compound protects against the progression of metabolic dysfunction-associated steatotic liver disease. Article Snippet: .. After blocking, membranes were incubated overnight with primary antibodies at 4◦C: anti-IκBα (sc-371) and anti-JNK (sc7345) from Santa Cruz Biotechnology Inc.; anti-IL1β (AF-401-NA) from Bio-Techne R&D Systems; anti-cleaved caspase-3 (#9661), antiphospho-JNK (#4668), anti-phospho-p38 (#9211), anti-p38 (#9212), Incubation:Article Title: The inhibition of Il1β synthesis mediated by a novel pyridine-sulfonamide compound protects against the progression of metabolic dysfunction-associated steatotic liver disease. Article Snippet: .. After blocking, membranes were incubated overnight with primary antibodies at 4◦C: anti-IκBα (sc-371) and anti-JNK (sc7345) from Santa Cruz Biotechnology Inc.; anti-IL1β (AF-401-NA) from Bio-Techne R&D Systems; anti-cleaved caspase-3 (#9661), antiphospho-JNK (#4668), anti-phospho-p38 (#9211), anti-p38 (#9212), Recombinant:Article Title: RAC1P29S Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies phospho-AKT (T308) CST #13038 phospho-AKT (S473) CST #9271 phospho-AKT (S473) CST #4060 AKT CST #2920 phospho-ERK1/2 (T202/T204) CST #9101 ERK1/2 CST #9107 phospho-PAK1/2 (S199/192) CST #2605 phospho-PAK1/2 (T423/402) CST #2601 PAK1/2/3 CST #2604 phospho-MEK1/2 (S217/221) CST #9145 RAC1 (23A8) Merck Millipore 05-389 Vinculin (hVIN-1) Sigma-Aldrich V9131 Myc (9E10) In-house (CRUK LRI) N/A Vimentin (EPR3776) Abcam ab92547 N-cadherin CST #13116 c-Jun CST #9165 |
![A subpopulation of RGCs express the stress marker phosphorylated c-JUN <t>(p-cJUN).</t> (A) Whole mount image ( Cx3cr1-Gfp/+ ) of e14.5 retina showing that a subset of RGCs (Brn3a+; red) express nuclear p-cJUN (white; yellow arrows). Boxed regions show enlarged region and label for p-cJUN alone or Brn3a alone (A′) . Scale bar = 10 μm. (B) Whole mount image (e14.5 Cx3cr1-Gfp/+ ) showing microglia (GFP) internalizing an RGC (Brn3a + red) labeled with p-cJUN (white) using HCR IHC. Scale bar = 1 μm. (C) Whole mount images showing RGCs (Brn3a+; red) with nuclear p-cJUN (white) in control mice (WT) and Mertk/CR3 dKO mice. Yellow arrows indicate double positive p-cJUN and Brn3a staining. (D) Quantification of double positive p-cJUN + Brn3a + RGCs per mm 2 in e14.5 control and Mertk/CR3 dKO mice. *** p < 0.01 unpaired t -test [ N = 4 (WT), 5 (Mertk CR3 dKO)]. (E) Quantification of p-cJUN + Brn3a + RGCs per mm 2 in e14.5 and e16.5 Mertk/CR3 dKO mice. * p < 0.05 Welch’s t -test [ N = 5 (e14.5), 4 (e16.5)]. (F) Quantification of p-cJUN + Brn3a + RGCs per mm 2 in P0 control, Mertk KO and Mertk/CR3 dKO mice. ns, not significant. Welch’s one-way ANOVA with Brown–Forsythe variance test [ N = 7 (WT), 7 (Mertk KO), 6 (Mertk CR3 dKO)]. (G) Whole mount retina images to show vehicle treated Axl KO mice with RGCs (Brn3a+; red) expressing nuclear p-cJUN (white) and microglia present (IBA1+; green). Scale bar = 500 μm. Boxed regions show enlarged area (G′) with yellow arrows indicating double positive p-cJUN and Brn3a staining. Scale bars = 100-10 μm. (H) Whole mount retina images to show Axl KO PLX treated mice with depletion of microglia (IBA1; green) and RGCs (Brn3a+; red) with nuclear p-cJUN (white) expression remaining. Boxed regions show enlarged area (H′) with yellow arrows indicating double positive p-cJUN and Brn3a staining. Scale bars = 100 to 10 μm.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_5010/pmc12715010/pmc12715010__fncel-19-1719791-g002.jpg)